Literature DB >> 2645077

Osteogenic stem cells and the stromal system of bone and marrow.

J N Beresford1.   

Abstract

According to current hypothesis, cells of the osteogenic lineage, which includes both osteoblasts and chondroblasts, are derived from a stromal stem cell in the postnatal organism. That there exist osteogenic precursors in association with the soft, fibrous tissue of the marrow stroma is well established. An osteogenic tissue comprised of cartilage and bone is formed when marrow or marrow cell suspensions are cultured in vivo within diffusion chambers. Bone with a functional marrow organ is formed when marrow or marrow cell suspensions are transplanted heterotopically, e.g., under the renal capsule. Cultures of marrow stromal fibroblasts are readily established in vitro from single-cell bone marrow suspensions. Such cultures do not demonstrate overt differentiation in an osteogenic direction in vitro. When transplanted in vivo, however, they differentiate to form cartilage and bone in diffusion chambers and bone with a functional marrow organ when transplanted heterotopically. Single-cell bone marrow suspensions can be cultured in vitro under conditions that facilitate the formation of stromal fibroblast colonies. Circumstantial evidence supports the conclusion that each colony is derived from a single initiating cell termed a colony-forming unit-fibroblastic (CFU-F). A proportion of CFU-F demonstrates extensive proliferative potential both in vitro and in vivo. In vitro the extensive proliferative potential of a subset of CFU-F has been shown to be associated with a capacity for extensive self-renewal. On transplantation in vivo, the progeny of a proportion of CFU-F has been shown to be capable of proliferating and differentiating into all the stromal cell lines necessary for the formation of bone and reconstitution of the hematopoietic inductive microenvironment. These findings provide strong circumstantial evidence to support the hypothesis that there are stem cells present within the marrow stroma that are capable of giving rise to cells of a number of different lineages, including those of the osteogenic lineage (chondroblasts and osteoblasts).

Entities:  

Mesh:

Year:  1989        PMID: 2645077

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  42 in total

Review 1.  Growth factor delivery for tissue engineering.

Authors:  J E Babensee; L V McIntire; A G Mikos
Journal:  Pharm Res       Date:  2000-05       Impact factor: 4.200

2.  In vivo bone formation by human bone marrow cells: effect of osteogenic culture supplements and cell densities.

Authors:  S C Mendes; I Van Den Brink; J D De Bruijn; C A Van Blitterswijk
Journal:  J Mater Sci Mater Med       Date:  1998-12       Impact factor: 3.896

3.  Mesenchymal stem cells combined with biphasic calcium phosphate ceramics promote bone regeneration.

Authors:  T L Livingston; S Gordon; M Archambault; S Kadiyala; K McIntosh; A Smith; S J Peter
Journal:  J Mater Sci Mater Med       Date:  2003-03       Impact factor: 3.896

4.  PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors.

Authors:  Toru Akune; Shinsuke Ohba; Satoru Kamekura; Masayuki Yamaguchi; Ung-Il Chung; Naoto Kubota; Yasuo Terauchi; Yoshifumi Harada; Yoshiaki Azuma; Kozo Nakamura; Takashi Kadowaki; Hiroshi Kawaguchi
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

Review 5.  Molecular mediators of mesenchymal stem cell biology.

Authors:  Maria P Alfaro; Sarika Saraswati; Pampee P Young
Journal:  Vitam Horm       Date:  2011       Impact factor: 3.421

6.  Quality of Cell Products: Authenticity, Identity, Genomic Stability and Status of Differentiation.

Authors:  Kurt E J Dittmar; Meike Simann; Nadia Zghoul; Oliver Schön; Wilhelm Meyring; Horst Hannig; Lars Macke; Wilhelm G Dirks; Konstantin Miller; Henk S P Garritsen; Werner Lindenmaier
Journal:  Transfus Med Hemother       Date:  2010-03-08       Impact factor: 3.747

7.  Mouse mandible contains distinctive mesenchymal stem cells.

Authors:  T Yamaza; G Ren; K Akiyama; C Chen; Y Shi; S Shi
Journal:  J Dent Res       Date:  2010-11-12       Impact factor: 6.116

Review 8.  Distinct effects of PPARgamma insufficiency on bone marrow cells, osteoblasts, and osteoclastic cells.

Authors:  Hiroshi Kawaguchi; Toru Akune; Masayuki Yamaguchi; Shinsuke Ohba; Naoshi Ogata; Ung-il Chung; Naoto Kubota; Yasuo Terauchi; Takashi Kadowaki; Kozo Nakamura
Journal:  J Bone Miner Metab       Date:  2005       Impact factor: 2.626

9.  Practical Modeling Concepts for Connective Tissue Stem Cell and Progenitor Compartment Kinetics.

Authors:  George F. Muschler; Ronald J. Midura; Chizu Nakamoto
Journal:  J Biomed Biotechnol       Date:  2003

10.  Use of small interfering ribonucleic acids to inhibit the adipogenic effect of alcohol on human bone marrow-derived mesenchymal cells.

Authors:  Qiang Huang; Hui Zhang; Fu-xing Pei; Zhi-yu Chen; Guang-lin Wang; Bin Shen; Jing Yang; Zong-ke Zhou; Qing-quan Kong
Journal:  Int Orthop       Date:  2009-12-05       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.